In Australia, approximately 75% of children with allergies will experience persistent allergies, including anaphylaxis, into adulthood. Anaphylaxis is the most severe form of allergic reaction. It develops rapidly in response to allergen exposure and can be life-threatening or, in some cases, fatal. Living with the risk of anaphylaxis is often associated with a high emotional burden,…

Read More

Today (Friday, 1 October, 2021), adults living with severe corneal inflammation from dry eye disease (DED) that has not improved with the use of artificial tears, will gain affordable access to a new, once-daily treatment option on the Pharmaceutical Benefits Scheme (PBS). In-licensed for the first time in Australia by Seqirus – a wholly-owned subsidiary…

Read More

The 2021 – 2022 Federal Budget announcement includes some key changes for the healthcare industry. Notably, this budget delivers the largest investment in aged care and the largest investment in response to a Royal Commission in Australia’s history. The funding will work to afford older Australians greater respect, care and dignity through a five-pillar plan…

Read More

As millions of people around the world eagerly await their COVID-19 vaccinations, this year’s World Immunisation Week (WIW), which falls in the last week of April, has come at a fitting time. Organised by the World Health Organization (WHO), this year’s theme is ‘vaccines bring us closer’, aiming to increase global engagement around immunisation, and…

Read More